BrainStorm completes registered public offering of common stock

Download PDF Copy

Jul 20 2012

BrainStorm Cell Therapeutics Inc. (OTCBB:BCLI), an innovative developer of adult stem cell technologies and Central Nervous System (CNS) therapeutics, today announced that it completed a registered public offering of 19,818,972 shares of common stock at a price per share of $0.29 and warrants to purchase 14,864,229 shares of common stock at an exercise price of $0.29 per share, representing gross proceeds of $5,747,502.

Maxim Group LLC served as the lead placement agent for the offering and Leader Underwriters (1993) Ltd. acted as a sub-agent of the placement agent.

Source: BrainStorm Cell Therapeutics, Inc

Posted in: Business / Finance

Tags: B Cell, Bone, Cell, Central Nervous System, Exercise, Lou Gehrig's Disease, Nervous System, Stem Cells, T-Cell, Therapeutics

Comments (0)

Download PDF Copy

Suggested Reading

Terumo Blood and Cell Technologies and FUJIFILM Irvine Scientific collaborate to accelerate T cell expansion for cell therapy developers

Terumo Blood and Cell Technologies and FUJIFILM Irvine Scientific collaborate to accelerate T cell expansion for cell therapy developers

Rice researchers develop new construction kit for engineering smart cells

Rice researchers develop new construction kit for engineering smart cells

Heart attack recovery enhanced by human stem cell spheroids, study shows

Heart attack recovery enhanced by human stem cell spheroids, study shows

Researchers develop tool to measure biological age in individual cell types

Researchers develop tool to measure biological age in individual cell types

Spatial aging clocks reveal how T cells and neural stem cells shape brain aging

Spatial aging clocks reveal how T cells and neural stem cells shape brain aging

PIN1 protein found to be a significant driver of bladder cancer

PIN1 protein found to be a significant driver of bladder cancer

Study offers a promising regenerative therapy for osteoarthritis

Study offers a promising regenerative therapy for osteoarthritis

Inflammasome protects stem cells from becoming cancerous

Inflammasome protects stem cells from becoming cancerous

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Lower force leads to faster cell movement on aligned collagen fibers